MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
about
Vaccines for Emerging Infectious Diseases: lessons from MERS coronavirus and Zika virus.Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.MERS-CoV: Understanding the Latest Human Coronavirus Threat.Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.
P2860
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
@en
type
label
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
@en
prefLabel
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
@en
P2093
P2860
P1433
P1476
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
@en
P2093
David C Flyer
Gale E Smith
Gregory M Glenn
Matthew B Frieman
P2860
P304
P356
10.1016/J.VACCINE.2017.02.012
P407
P577
2017-02-23T00:00:00Z